A critical review of the dextroamphetamine transdermal system for the treatment of ADHD in adults and pediatric patients

INTRODUCTION: The dextroamphetamine transdermal system (d-ATS) is a stimulant patch recently approved by the United States (U.S.) Food and Drug Administration for the treatment of attention-deficit/hyperactivity disorder (ADHD).

via https://pubmed.ncbi.nlm.nih.gov/38630024/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=None&utm_content=1HYeX0emtvYgH07Wkz0a8n9otrdMd-JIklc_uo0I5vh1u9WMEy&fc=None&ff=20240418010810&v=2.18.0.post9+e462414